Kosmidis C - Search Results

1

Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.

Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW. Bongomin F, et al. Among authors: kosmidis c. PLoS One. 2018 Apr 10;13(4):e0193732. doi: 10.1371/journal.pone.0193732. eCollection 2018. PLoS One. 2018. PMID: 29634721 Free PMC article.

2

The clinical spectrum of pulmonary aspergillosis.

Kosmidis C, Denning DW. Kosmidis C, et al. Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29. Thorax. 2015. PMID: 25354514 Review.

3

Republished: The clinical spectrum of pulmonary aspergillosis.

Kosmidis C, Denning DW. Kosmidis C, et al. Postgrad Med J. 2015 Jul;91(1077):403-10. doi: 10.1136/postgradmedj-2014-206291rep. Postgrad Med J. 2015. PMID: 26187954 Review.

4

Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis.

Kosmidis C, Powell G, Borrow R, Morris J, Alachkar H, Denning DW. Kosmidis C, et al. Vaccine. 2015 Dec 16;33(51):7271-7275. doi: 10.1016/j.vaccine.2015.10.114. Epub 2015 Nov 3. Vaccine. 2015. PMID: 26546263

5

Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).

Al-Shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW. Al-Shair K, et al. Among authors: kosmidis c. Respir Med. 2016 May;114:117-22. doi: 10.1016/j.rmed.2016.03.020. Epub 2016 Apr 2. Respir Med. 2016. PMID: 27109821 Free article.

6

Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndrome.

Kosmidis C, Newton P, Muldoon EG, Denning DW. Kosmidis C, et al. Infect Dis (Lond). 2017 Apr;49(4):296-301. doi: 10.1080/23744235.2016.1232861. Epub 2016 Sep 23. Infect Dis (Lond). 2017. PMID: 27658458

7

Challenges in the management of chronic pulmonary aspergillosis.

Kosmidis C, Muldoon EG. Kosmidis C, et al. Med Mycol. 2017 Jan 1;55(1):63-68. doi: 10.1093/mmy/myw119. Epub 2016 Dec 2. Med Mycol. 2017. PMID: 27915300 Review.

8

Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis.

Bongomin F, Harris C, Foden P, Kosmidis C, Denning DW. Bongomin F, et al. Among authors: kosmidis c. J Fungi (Basel). 2017 May 29;3(2):26. doi: 10.3390/jof3020026. J Fungi (Basel). 2017. PMID: 29371544 Free PMC article.

9

Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.

Rodriguez-Goncer I, Harris C, Kosmidis C, Muldoon EG, Newton PJ, Denning DW. Rodriguez-Goncer I, et al. Among authors: kosmidis c. Int J Antimicrob Agents. 2018 Aug;52(2):258-264. doi: 10.1016/j.ijantimicag.2018.06.001. Epub 2018 Jun 12. Int J Antimicrob Agents. 2018. PMID: 29906567

10

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.

Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF; on behalf of CPAnet. Alastruey-Izquierdo A, et al. Among authors: kosmidis c. Respiration. 2018;96(2):159-170. doi: 10.1159/000489474. Epub 2018 Jul 6. Respiration. 2018. PMID: 29982245 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters